Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study. - Shin J; Cha DH; Bae WH; Jung IH; Hong SP; Kim SH; Do JY; Hwang WM; Koh YY; Mancia G; Manolis AJ; Lee M (Clinical hypertension, 2025)